Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;85(5):609-626.
doi: 10.1007/s40265-025-02172-2. Epub 2025 Mar 24.

Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges

Sharmin Ghaznavi  1   2 , Sarah G Richter  3
Affiliations
Review

Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges

Sharmin Ghaznavi et al. Drugs. 2025 May.

Abstract

There has been a recent resurgence in research on psychedelics as therapeutic agents for psychiatric conditions. This leading article outlines the studies to date of classic psychedelic treatments for treatment-resistant depression and major depression, including psilocybin, ayahuasca, dimethyltryptamine (DMT), and O-methyl-bufotenine (5-Me-O DMT). We discuss the potential of expanding treatment options for depression based on the data available, as well as the difficulties and limitations of research on psychedelics that make assessing that potential more challenging.

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: SG acknowledges support from the Arielle Soussan Memorial Fund for Psychedelic Research and the Goldsmith and Malievskaia Family Fund for Clinical Neuroscience Research. Conflict of interest: SG reports ownership of stock in atai Life Sciences. SR has no reported conflict of interest. Availability of data and material: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Code availability: Not applicable. Author contributions: SG and SR conceptualized, reviewed the literature, wrote, and edited the manuscript. Both authors have read and approved the final version of the manuscript and agree to be accountable for the work.

References

    1. Major Depressive Disorder: Developing Drugs for Treatment Guidance for Industry. 2018.
    1. Lee B, Wang Y, Carlson SA, Greenlund KJ, Lu H, Liu Y, et al. National, state-level, and county-level prevalence estimates of adults aged ≥ 18 years self-reporting a lifetime diagnosis of depression—United States, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2023 [cited 2024 May 31];72. https://www.cdc.gov/mmwr/volumes/72/wr/mm7224a1.htm .
    1. Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiat. 2018;75(4):336–46. - DOI
    1. Bains N, Abdijadid S. Major depressive disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 May 22]. http://www.ncbi.nlm.nih.gov/books/NBK559078/ .
    1. Heart disease and depression: a two-way relationship | NHLBI, NIH [Internet]. 2017 [cited 2024 May 23]. https://www.nhlbi.nih.gov/news/2017/heart-disease-and-depression-two-way... .

MeSH terms

LinkOut - more resources